Texas Bank & Trust’s DexCom DXCM Stock Holding History

Texas Bank & Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Hold	3,500	–	–	0.08%	177
2026 Q1	$220K	Hold	3,500	–	–	0.08%	169
2025 Q4	$232K	Buy	+3,500	New	+$226K	0.08%	167

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Texas Bank & Trust's DXCM Position: Q2 2026 in Review

Texas Bank & Trust held its DexCom (DXCM) position steady in Q2 2026 at 3,500 shares worth $236K. The position accounts for 0.08% of the portfolio, ranked #177.

Texas Bank & Trust first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Texas Bank & Trust held 3,500 shares of DexCom worth $236K as of Q2 2026.
Texas Bank & Trust left its DexCom share count unchanged in Q2 2026.
DexCom made up 0.08% of Texas Bank & Trust's portfolio in Q2 2026, its #177 holding.
Texas Bank & Trust first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.